NHS long-term plan: Growing importance of prevention medicine
“The challenge now is for the NHS to respond to this changing landscape and to focus on preventing as well as treating the conditions...
Have analytics been relegated to a reporting function?
Have business analytics been pushed to the background? Business information upgraded, smart CRM datasets, the Predictive Analytics silver bullet and other fairy tales.
Is Brexit good news for pharma?
James Burt, Executive Vice President EMENA, Accord Healthcare, asks whether Brexit will in fact present an opportunity for positive change in pharma and healthcare.
What do NHS changes mean for tech innovation?
Could changes at the top mean fresh opportunities for tech innovation?
Read this in the August issue of Pf Magazine.
For some time it has been...
At the heart of it: The vital role of pharmacies in community health
Read this in the August issue of Pf Magazine.
Community pharmacy has a clear role in promoting and supporting the public’s health. There’s an accessible...
Five ways blockchain is impacting healthcare
Blockchain is one of the most talked about technologies at the moment and boasts huge potential to transform how we deliver healthcare and revolutionise...
Brexit: What will it mean for the regulation of medicines?
What are the implications for the movement of medicines from and into the UK, post-brexit? Mark Quick, executive vice president of corporate development at Recipharm, comments on the current situation and the potential implications of the UK exiting the European Union (EU).
The five key areas to drive growth of UK’s pharmaceutical sector
These 5 things are what pharmaceutical companies should be focusing on to maximise their growth in the UK.
The NHS is 70 – Claudia Rubin asks: what’s next?
From birthday teas to big policy, blood donor drives to special 10p coins, the 70th anniversary of the creation of the NHS is getting...
It’s time for a greater role for pharmacists in asthma management
I’ve returned from a Saturday morning in community pharmacy practice and am reflecting on the number of patients I saw with asthma. I checked...
Latest articles
Big Sugar and neglect by global health community fuel oral health crisis
Oral health has been isolated from traditional healthcare and health policy for too long, despite the major global public health burden of oral diseases,...
New statistics show decrease in animals used for R&D
The Home Office has released its annual statistics on animals used in research in Great Britain. It shows 3.52 million procedures were carried out...
New insight into microRNA function can give gene therapy a boost
New insight into microRNA function has been published by scientists at the University of Eastern Finland and the University of Oxford. They have shown that...
Popular articles
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Gene silencing therapy for hereditary amyloidosis approved by NICE
NICE has approved a first-in-class gene silencing therapy for hereditary amyloidosis. RNA interference (RNAi) therapeutics company, Alnylam UK Limited has welcomed a decision from the...
AstraZeneca to appeal NICE’s osimertinib decision
AstraZeneca to appeal NICE's osimertinib decision following it not being recommended for use within NHS England. AstraZeneca will appeal a decision by the National Institute...
Top 5 R&D hubs in the UK
Read this cover story in the June issue of Pf Magazine here. Join us on a tour of inspirational research and development centres. ...
How to write a standout CV
The job market is getting more competitive by the day, as highly-qualified candidates fiercely compete for the top jobs. A carefully constructed CV is...